MedTrace Logo

Reflectance Confocal Microscopy to Diagnose BCC

NCT03509415 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 324

Last updated 2024-04-16

No results posted yet for this study

Summary

It is proposed to undertake a study to determine the diagnostic utility of using RCM for the diagnosis of Basal Cell Carcinoma (BCC) in a tertiary referral centre as outlined by the recent NICE report (Nov 2015). This will allow an assessment of the potential to avoid diagnostic biopsy within the treatment pathway.

Conditions

Interventions

DIAGNOSTIC_TEST

In-vivo imaging

Skin cancer is imaged using RCM and a diagnosis is recorded before patient is returned to standard of care (biopsy).

Sponsors & Collaborators

  • Skin Care Network Ltd.

    lead INDUSTRY

Principal Investigators

  • Howard Stevens, MA PhD · Skin Care Network Ltd.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-15
Primary Completion
2019-12-28
Completion
2019-12-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03509415 on ClinicalTrials.gov